Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease (Q34471821)

2 August 2017

Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease (English)

1 reference

2 August 2017

Erdheim-Chester disease

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Eunhee Kim

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Karen Leroy

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Jean Emmanuel Kahn

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Philippe Nizard

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Valerie Taly

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Omar Abdel-Wahab

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Jean-François Emile

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Zofia Hélias-Rodzewicz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Fleur Cohen-Aubart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Frédéric Charlotte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

David M Hyman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Raajit Rampal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Minal Patel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Chezi Ganzel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Shlomzion Aumann

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Gladwys Faucher

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Catherine Le Gall

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Magali Colombat

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Salim Trad

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Jean Donadieu

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Zahir Amoura

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Julien Haroche

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

22 August 2014

1 reference

2 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

3016-3019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease

5 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

Somatic activating ARAF mutations in Langerhans cell histiocytosis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignancies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

Improved survival with MEK inhibition in BRAF-mutated melanoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

Recurrent BRAF mutations in Langerhans cell histiocytosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

Detection of an NRAS mutation in Erdheim-Chester disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

BRAFV600EMutation in a Histiocytic Sarcoma Arising From Hairy Cell Leukemia

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224196

BRAF mutations in Erdheim-Chester disease

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25150293

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1182/BLOOD-2014-04-570937

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25150293%20AND%20SRC:MED&resulttype=core&format=json